Celleration , Inc.

Celleration®, Inc. a privately held medical device company was founded in 1999, to develop and commercialize its therapeutic ultrasound platform. The patented MIST Technology utilizes low intensity ultrasonic sound waves to produce an energized mist of sterile saline in a non-contact fashion. Critical to the Company's strategy is ongoing clinical and scientific research to provide evidence supporting the efficacy of this new technology. The Company's initial focus has been the chronic diabetic foot ulcer market and it has recently completed a prospective, randomized, double-masked, sham controlled multi-center study in diabetic foot ulcers which resulted in a statistically significant improvement in the rate of wound closure and time to wound closure. ( www.celleration.com )